Hyderabad (Telangana): Prime Minister Narendra Modi will reportedly visit Hyderabad on Saturday (November 28) to check on the progress of the COVID vaccine being developed by Bharat Biotech.
The Covid-19 vaccine, Covaxin, being developed by Bharat Biotech, is now undergoing the phase-3 trials.
Last month the vaccine maker said it had successfully completed interim analysis of Phase I and II trials of the vaccine and is initiating Phase-III trials in 26,000 participants.
Covaxinis being developed by BharatBiotech, in collaboration with the Indian Council of Medical Research (ICMR) - National Institute of Virology (NIV).
Bharat Biotech in September said it entered into a licensing agreement with Washington University School of Medicine in St. Louis for a novel "chimp-adenovirus" (Chimpanzee adenovirus), single dose intranasal vaccine for COVID-19.
Read: Phase-3 trial of Bharat Biotech's Covaxin commences in AIIMS
Speaking at a programme earlier this month, Krishna Ella, Chairman and Managing Director, Bharat Biotech, said the company is also working on another vaccine for COVID-19 which would be in the form of nasal drops and can be ready by next year.
(With inputs from agencies)
